Medicare Coverage for Kidney Disease & ESRD: 2025 Guide

Kidney disease is unique in Medicare law: End-Stage Renal Disease (ESRD) is one of only two conditions that qualify non-elderly Americans for Medicare before age 65 (the other being ALS). Medicare covers dialysis, kidney transplants, and post-transplant immunosuppressive drugs — but with important rules, deadlines, and a 30-month coordination period that catches many patients off guard.

Kidney Disease & ESRD Coverage Quick Reference

Who Qualifies for Medicare Due to Kidney Disease

Unlike most Medicare coverage which begins at age 65, ESRD allows younger Americans to qualify for Medicare. You qualify for Medicare based on ESRD if:

• You have permanent kidney failure requiring regular dialysis or a kidney transplant
• You are eligible for Social Security or Railroad Retirement Board benefits (or are a dependent of someone who is)
• You have worked the required amount under Social Security (or your spouse has)

You can apply for Medicare due to ESRD at your local Social Security office at any time — there is no open enrollment restriction.

The 30-Month Coordination Period: The Most Expensive Trap

If you have ESRD and are also covered by employer group health insurance, Medicare does not immediately become your primary payer. There is a 30-month coordination period during which your employer plan pays first and Medicare pays second.

How this works:

1. Month 1–30: Your employer group health plan is primary; Medicare is secondary (pays remaining costs)
2. Month 31+: Medicare becomes your primary payer

Why this matters: If you drop your employer insurance during the 30-month period, assuming Medicare will cover your dialysis costs, you may face very large out-of-pocket expenses. The 30-month coordination period still applies to your Medicare coverage, meaning Medicare was still only secondary to the group plan you dropped.

What to do: Keep employer coverage during the 30-month period whenever possible. The combination of employer insurance (primary) + Medicare (secondary) often means very low out-of-pocket costs for dialysis during those 30 months.

Dialysis Coverage: In-Center vs. Home

Medicare covers both in-center and home dialysis. Home dialysis has significant advantages for quality of life and potentially outcomes, and Medicare's coverage is comparable.

In-Center Hemodialysis

• Typically 3 sessions per week, 3–4 hours each
• All treatment costs covered under Part B (80% after deductible)
• Must use a Medicare-certified dialysis facility
• Transportation to dialysis sessions may qualify for coverage through some Medicare Advantage plans

Home Hemodialysis

• Can be done more frequently (5–7x/week) with better blood pressure control and quality of life for many patients
• Medicare covers the dialysis machine, supplies, water treatment system, and training
• A trained caregiver is typically required to be present during sessions
• Caregiver training is also covered by Medicare

Peritoneal Dialysis (CAPD/CCPD)

• Uses the peritoneum (abdominal lining) as a filter; can be done while sleeping (CCPD)
• Supplies, equipment, and training covered under Part B
• More independence — no caregiver required for most patients

Kidney Transplant Coverage

Medicare covers kidney transplantation when performed at a Medicare-certified transplant center. Coverage includes:

• Transplant surgery (Part A inpatient hospital coverage)
• Pre-transplant evaluation and workup (Part B)
• Living donor evaluation, surgery, and recovery costs (covered by the recipient's Medicare)
• Post-transplant monitoring and follow-up
• Immunosuppressive drugs — now covered indefinitely (see below)

After a successful kidney transplant, Medicare coverage for dialysis ends. Medicare continues to cover post-transplant care including immunosuppressive medications, kidney function monitoring, and related medical care.

Immunosuppressive Drug Coverage: Now Permanent

This is one of the most important recent changes in ESRD Medicare coverage. Kidney transplant recipients must take immunosuppressive medications for life to prevent rejection. Previously, Medicare Part B coverage for these drugs ended 36 months after transplant (if Medicare eligibility was based solely on ESRD).

The 2023 change: Starting January 1, 2023, the Immunosuppressive Drug Benefit was made permanent. Medicare now covers immunosuppressive drugs for the life of the transplant — eliminating the 36-month cliff that caused many kidney recipients to lose their transplants due to inability to afford anti-rejection medications.

Coverage details:

• Immunosuppressive drugs may be covered under Part B (physician-administered) or Part D (self-administered)
• Part B coverage: 20% coinsurance after the Part B deductible
• Part D coverage: Standard Part D cost-sharing (varies by plan and tier)
• Medigap Plan G covers the 20% Part B coinsurance, making immunosuppressive drugs free (after deductible)

Medicare Advantage for ESRD Patients (Post-2021)

Since January 2021, ESRD patients can enroll in Medicare Advantage plans. Before evaluating MA plans, ESRD patients should assess:

• Network coverage: Is your dialysis center in-network? Out-of-network dialysis costs can be very high under MA plans
• Prior authorization: MA plans may require prior authorization for dialysis sessions, transplant evaluations, or medications
• Drug formulary: Are your immunosuppressive drugs covered on the plan's formulary?
• Specialist access: Is your nephrologist in-network?
• Maximum out-of-pocket limit: MA plans cap OOP costs annually; Original Medicare does not

D-SNPs (Dual Eligible Special Needs Plans) and C-SNPs designed for chronic conditions including ESRD may offer additional benefits like transportation to dialysis and care coordination.

Chronic Kidney Disease (CKD): Coverage Before ESRD

For patients with CKD who have not yet reached ESRD (stages 1–4), Medicare coverage under Parts A and B applies to standard medical care:

• Nephrologist visits (Part B)
• Lab work monitoring kidney function (Part B)
• Blood pressure medications critical for slowing CKD progression (Part D)
• Medical nutrition therapy (Part B) — covered for CKD stages 3–4
• SGLT2 inhibitors (empagliflozin, dapagliflozin) for CKD — covered under Part D; these new medications have been shown to slow CKD progression significantly

Frequently Asked Questions